Abstract CT283: Phase 3 MK-2870-007 study: MK-2870 (SKB264) plus pembrolizumab vs pembrolizumab alone as first-line treatment for metastatic non-small-cell lung cancer with PD-L1 tumor proportion score (TPS) ≥50

Frost, Nikolaj ; Ghori, Razi ; Roy, Ananya ; Nunes, Ana Tablante ; Yang, James Chih-Hsin

Texto completo disponível

Abstract PS12-07: Lenvatinib plus pembrolizumab for previously treated, advanced triple-negative breast cancer: Early results from the multicohort phase 2 LEAP-005 study

Chung, Hyun Cheol ; Saada-Bouzid, Esma ; Muñoz, Federico Longo ; Yanez, Eduardo ; Im, Seock-Ah ; Castanon, Eduardo ; Graham, Donna M. ; Garcia-Corbacho, Javier ; Lopez, Juanita ; Ghori, Razi ; Dutcus, Corina ; Smith, Alan ; Norwood, Kevin ; Gomez-Roca, Carlos

Texto completo disponível

Clinical relevance of vilazodone treatment in patients with major depressive disorder: categorical improvement in symptoms

Culpepper, Larry ; Mathews, Maju ; Ghori, Razi ; Edwards, John

United States: Physicians Postgraduate Press, Inc

Texto completo disponível

Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma

Ribas, Antoni ; Lawrence, Donald ; Atkinson, Victoria ; Agarwal, Sachin ; Miller, Wilson H ; Carlino, Matteo S ; Fisher, Rosalie ; Long, Georgina V ; Hodi, F Stephen ; Tsoi, Jennifer ; Grasso, Catherine S ; Mookerjee, Bijoyesh ; Zhao, Qing ; Ghori, Razi ; Moreno, Blanca Homet ; Ibrahim, Nageatte ; Hamid, Omid

eScholarship, University of California

Sem texto completo

Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma

Ribas, Antoni ; Lawrence, Donald ; Atkinson, Victoria ; Agarwal, Sachin ; Miller, Jr, Wilson H ; Carlino, Matteo S ; Fisher, Rosalie ; Long, Georgina V ; Hodi, F Stephen ; Tsoi, Jennifer ; Grasso, Catherine S ; Mookerjee, Bijoyesh ; Zhao, Qing ; Ghori, Razi ; Moreno, Blanca Homet ; Ibrahim, Nageatte ; Hamid, Omid

United States: Nature Publishing Group

Texto completo disponível

Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma

Ascierto, Paolo Antonio ; Ferrucci, Pier Francesco ; Fisher, Rosalie ; Del Vecchio, Michele ; Atkinson, Victoria ; Schmidt, Henrik ; Schachter, Jacob ; Queirolo, Paola ; Long, Georgina V ; Di Giacomo, Anna Maria ; Svane, Inge Marie ; Lotem, Michal ; Bar-Sela, Gil ; Couture, Felix ; Mookerjee, Bijoyesh ; Ghori, Razi ; Ibrahim, Nageatte ; Moreno, Blanca Homet ; Ribas, Antoni

United States: Nature Publishing Group

Texto completo disponível

Efficacy and Safety of Nemtabrutinib, a Wild-Type and C481S-Mutated Bruton Tyrosine Kinase Inhibitor for B-Cell Malignancies: Updated Analysis of the Open-Label Phase 1/2 Dose-Expansion Bellwave-001 Study

Woyach, Jennifer A. ; Flinn, Ian W. ; Awan, Farrukh T. ; Eradat, Herbert ; Brander, Danielle ; Tees, Michael ; Parikh, Sameer A. ; Phillips, Tycel J. ; Ghori, Razi ; Reddy, Nishitha M. ; Farooqui, Mohammed Z.H. ; Byrd, John C. ; Stephens, Deborah M.

Elsevier Inc

Texto completo disponível

Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study

Marabelle, Aurelien ; Le, Dung T ; Ascierto, Paolo A ; Di Giacomo, Anna Maria ; De Jesus-Acosta, Ana ; Delord, Jean-Pierre ; Geva, Ravit ; Gottfried, Maya ; Penel, Nicolas ; Hansen, Aaron R ; Piha-Paul, Sarina A ; Doi, Toshihiko ; Gao, Bo ; Chung, Hyun Cheol ; Lopez-Martin, Jose ; Bang, Yung-Jue ; Frommer, Ronnie Shapira ; Shah, Manisha ; Ghori, Razi ; Joe, Andrew K ; Pruitt, Scott K ; Diaz, Jr, Luis A

United States: American Society of Clinical Oncology

Texto completo disponível

First-in-Human Study of the Reversible BTK Inhibitor Nemtabrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia and B-Cell Non-Hodgkin Lymphoma

Woyach, Jennifer A ; Stephens, Deborah M ; Flinn, Ian W ; Bhat, Seema A ; Savage, Ronald E ; Chai, Feng ; Eathiraj, Sudharshan ; Reiff, Sean D ; Muhowski, Elizabeth M ; Granlund, Lindsey ; Szuszkiewicz, Lyndsey ; Wang, Wayne ; Schwartz, Brian ; Ghori, Razi ; Farooqui, Mohammed Z H ; Byrd, John C

United States

Texto completo disponível

KEYNOTE-022 part 3: a randomized, double-blind, phase 2 study of pembrolizumab, dabrafenib, and trametinib in BRAF-mutant melanoma

Ferrucci, Pier Francesco ; Di Giacomo, Anna Maria ; Del Vecchio, Michele ; Atkinson, Victoria ; Schmidt, Henrik ; Schachter, Jacob ; Queirolo, Paola ; Long, Georgina V ; Stephens, Rosalie ; Svane, Inge Marie ; Lotem, Michal ; Abu-Amna, Mahmoud ; Gasal, Eduard ; Ghori, Razi ; Diede, Scott J ; Croydon, Elizabeth S ; Ribas, Antoni ; Ascierto, Paolo Antonio

eScholarship, University of California

Sem texto completo